About Instituto Valenciano de Neurologia Pediatrica
"La actividad clínica del Instituto Valenciano de Neurología Pediátrica (INVANEP) está dedicada al diagnóstico y tratamiento de las alteraciones del sistema nervioso en la infancia y la adolescencia, completándose la labor asistencial con sesiones clínicas, actividades formativas y de investigación. Además, realizamos estudios complementarios como la electroencefalografía, vídeo-EEG, incluidos registros de sueño nocturno, así como análisis de potenciales evocados psicofisiológicos. - TDAH - Convulsiones y Epilepsia - Dificultades del Aprendizaje - Problemas del desarrollo del lenguaje - Seguimiento neuroevolutivo del recién nacido de riesgo y de la Parálisis - Cefaleas y Migraña - Trastorno del Espectro Autista - Retraso psicomotor - Etc."
Clinical Trials at Instituto Valenciano de Neurologia Pediatrica
During the past decade, Instituto Valenciano de Neurologia Pediatrica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Instituto Valenciano de Neurologia Pediatrica
According to Clinical.Site data, the most researched conditions in "Instituto Valenciano de Neurologia Pediatrica" are
"Attention Deficit Hyperactivity Disorder" (1 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials) and "Attention-deficit/Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Instituto Valenciano de Neurologia Pediatrica" in a lesser frequency.
Clinical Trials Intervention Types at Instituto Valenciano de Neurologia Pediatrica
Most popular intervention types in "Instituto Valenciano de Neurologia Pediatrica" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Extended-release Guanfacine Hydrochloride" (2 trials), "Atomoxetine Hydrochloride" (1 trials), "Extended-release Guanfacine HCl (Intuniv, SPD503)" (1 trials), "Placebo" (1 trials) and "Placebo Comparator" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Valenciano de Neurologia Pediatrica
The vast majority of trials in "Instituto Valenciano de Neurologia Pediatrica" are
3 trials for "All" genders.
Clinical Trials Status at Instituto Valenciano de Neurologia Pediatrica
Currently, there are NaN active trials in "Instituto Valenciano de Neurologia Pediatrica".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Instituto Valenciano de Neurologia Pediatrica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Valenciano de Neurologia Pediatrica, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".